HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kei Muro Selected Research

Anemia

1/2019Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.
1/2019Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial.
1/2017Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.
4/2010Multicenter phase II study of everolimus in patients with previously treated metastatic gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kei Muro Research Topics

Disease

137Neoplasms (Cancer)
05/2024 - 04/2002
129Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 01/2002
100Stomach Neoplasms (Stomach Cancer)
01/2024 - 12/2003
41Adenocarcinoma
11/2023 - 09/2011
40Neoplasm Metastasis (Metastasis)
09/2022 - 03/2003
28Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 06/2003
28Disease Progression
01/2022 - 05/2009
19Neutropenia
11/2023 - 12/2003
18Esophageal Squamous Cell Carcinoma
10/2023 - 11/2011
11Ascites
02/2021 - 11/2009
8Nausea
05/2024 - 01/2011
8Diarrhea
07/2022 - 05/2011
7Colonic Neoplasms (Colon Cancer)
01/2023 - 07/2011
7Vomiting
08/2020 - 08/2003
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2022 - 12/2016
6Anorexia
10/2022 - 08/2003
6Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 12/2003
6Hypertension (High Blood Pressure)
01/2019 - 10/2014
5Squamous Cell Carcinoma of Head and Neck
03/2024 - 11/2016
5Fatigue
07/2016 - 08/2003
5Breast Neoplasms (Breast Cancer)
10/2012 - 05/2002
4Cachexia
05/2024 - 12/2019
4Febrile Neutropenia
11/2023 - 01/2017
4Drug-Related Side Effects and Adverse Reactions
01/2022 - 12/2016
4Microsatellite Instability
06/2021 - 01/2019
4Leukopenia
08/2020 - 08/2011
4Anemia
01/2019 - 04/2010
4Thrombocytopenia (Thrombopenia)
01/2019 - 08/2011
4Infections
01/2019 - 04/2014
3Hyperglycemia
05/2024 - 10/2012
3Peripheral Nervous System Diseases (PNS Diseases)
11/2022 - 04/2015
3Hyponatremia
10/2022 - 04/2010
3Body Weight (Weight, Body)
01/2022 - 12/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 10/2007
3Interstitial Lung Diseases (Interstitial Lung Disease)
08/2021 - 03/2014
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2019 - 10/2007
3Hepatocellular Carcinoma (Hepatoma)
10/2019 - 04/2014
3Disseminated Intravascular Coagulation
09/2017 - 12/2011
3Carcinoma (Carcinomatosis)
01/2017 - 01/2013
3Jaundice (Icterus)
01/2016 - 07/2011

Drug/Important Bio-Agent (IBA)

53Bevacizumab (Avastin)FDA Link
03/2024 - 04/2009
51Fluorouracil (Carac)FDA LinkGeneric
03/2024 - 01/2002
48Irinotecan (Camptosar)FDA LinkGeneric
03/2024 - 08/2003
46Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2024 - 04/2006
37Leucovorin (Folinic Acid)FDA Link
03/2024 - 01/2002
29NivolumabIBA
01/2024 - 01/2017
27Cetuximab (Erbitux)FDA Link
03/2024 - 04/2009
26Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 01/2011
25Cisplatin (Platino)FDA LinkGeneric
03/2024 - 01/2009
23PlatinumIBA
04/2024 - 01/2009
22pembrolizumabIBA
04/2024 - 06/2016
22Biomarkers (Surrogate Marker)IBA
02/2024 - 06/2012
22RamucirumabIBA
08/2023 - 10/2014
16Panitumumab (Vectibix)FDA Link
02/2024 - 10/2007
15trifluridine tipiracil drug combinationIBA
03/2024 - 10/2012
14Capecitabine (Xeloda)FDA Link
01/2023 - 10/2010
13Immune Checkpoint InhibitorsIBA
04/2023 - 09/2016
13Monoclonal AntibodiesIBA
01/2023 - 07/2004
12taxaneIBA
04/2024 - 10/2012
11Trastuzumab (Herceptin)FDA Link
10/2020 - 05/2011
10Docetaxel (Taxotere)FDA Link
10/2023 - 11/2010
9ErbB Receptors (EGF Receptor)IBA
03/2024 - 10/2007
9human ERBB2 proteinIBA
03/2022 - 05/2011
7B7-H1 AntigenIBA
03/2024 - 11/2016
7Proteins (Proteins, Gene)FDA Link
10/2023 - 01/2013
7regorafenibIBA
11/2019 - 01/2017
6S-1 plus cisplatinIBA
01/2022 - 11/2010
6BilirubinIBA
10/2019 - 07/2011
5Taxoids (Taxanes)IBA
06/2023 - 06/2011
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 02/2012
5AntibodiesIBA
01/2019 - 01/2017
4Growth Factor ReceptorsIBA
01/2023 - 08/2010
4Antineoplastic Agents (Antineoplastics)IBA
04/2021 - 01/2008
4Cytotoxins (Cytolysins)IBA
09/2020 - 06/2011
4130-nm albumin-bound paclitaxelIBA
06/2020 - 07/2014
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2017 - 12/2016
4XELOXIBA
12/2016 - 10/2010
3anamorelinIBA
05/2024 - 12/2019
3Epidermal Growth Factor (EGF)IBA
02/2024 - 01/2013
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2023 - 01/2018
3gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
12/2019 - 04/2010
3Circulating Tumor DNAIBA
02/2019 - 12/2016
3Immunoglobulin G (IgG)IBA
01/2019 - 12/2017
3Alanine Transaminase (SGPT)IBA
01/2019 - 12/2016
3CreatinineIBA
10/2018 - 01/2017
3Dacarbazine (DIC)FDA LinkGeneric
09/2017 - 12/2011
3Sunitinib (Sutent)FDA Link
04/2014 - 12/2010

Therapy/Procedure

170Drug Therapy (Chemotherapy)
04/2024 - 01/2002
95Therapeutics
03/2024 - 12/2003
16Chemoradiotherapy
01/2023 - 06/2003
14Combination Drug Therapy (Combination Chemotherapy)
07/2021 - 11/2009
11Immunotherapy
04/2023 - 01/2017
9Neoadjuvant Therapy
11/2023 - 08/2015
6Radiotherapy
05/2017 - 11/2005
5Adjuvant Chemotherapy
01/2021 - 11/2008
4Intravenous Infusions
11/2023 - 10/2012
4Aftercare (After-Treatment)
01/2022 - 01/2015
4Drug Tapering
01/2019 - 05/2011
3Gastrectomy
01/2022 - 09/2004
3Induction Chemotherapy
02/2021 - 03/2009